Foren & Soziale Netzwerke zur CLARIVATE Aktie

 

Over the past month, CL has declined by 6.3%, and year-to-date, it's down 14.24%. The 52-week range is $77.09 to $102.61, indicating the stock is near its yearly low. Key Financials: Market Cap: $63.01 billion Revenue (TTM): $20.00 billion Net Income (TTM): $2.91 billion EPS (TTM): $3.56 P/E Ratio: 21.90 Forward P/E: 20.76 Dividend Yield: 2.67% ($2.08 annually, ex-dividend date Oct 17, 2025) Beta: 0.34 (low volatility) Analyst Outlook: Analysts rate CL as a "Moderate Buy" with a consensus price target of $93.50, suggesting a potential upside of 19.93%. Price targets range from $80 to $108. Recent analyst actions include downgrades (e.g., Wells Fargo maintaining a "Sell" rating at $80) and upgrades (e.g., Citigroup and UBS with "Strong Buy" ratings at $10